felin
infecti
periton
viru
fip
viru
fipv
caus
fatal
diseas
wild
domest
cat
develop
fipprevent
vaccin
requir
antigen
induc
antibodydepend
enhanc
helper
th
activ
play
import
role
protect
fipv
infect
present
studi
identifi
synthet
peptid
includ
linear
immunodomin
antibodybind
epitop
domain
protein
fipv
also
identifi
peptid
strongli
induc
activ
deriv
structur
protein
n
protein
fipv
base
previou
studi
satoh
et
al
epitopecontain
peptid
identifi
peptid
deriv
domain
type
fipv
contrast
epitopecontain
peptid
identifi
domain
type
ii
fipv
linear
immunodomin
antibodybind
epitop
contain
peptid
eleven
epitopecontain
peptid
common
serotyp
identifi
proteinderiv
peptid
peptid
contain
linear
immunodomin
antibodybind
epitop
peptid
deriv
n
protein
fipv
induc
significantli
stronger
activ
fipv
antigen
rescreen
peptid
identifi
peptid
select
administ
cpgodn
spf
cat
induc
activ
result
may
provid
import
inform
develop
peptidebas
vaccin
fipv
infect
felin
coronaviru
fcov
belong
alphacoronaviru
famili
coronavirida
fcov
mainli
compos
nucleocapsid
n
protein
membran
protein
peplom
spike
protein
fcov
classifi
serotyp
ii
accord
amino
acid
sequenc
protein
serotyp
consist
two
biotyp
felin
infecti
periton
viru
fipv
felin
enter
coronaviru
fecv
fecv
infect
asymptomat
cat
contrast
fipv
infect
caus
fatal
diseas
call
fip
cat
develop
fip
affect
sever
organ
central
nervou
system
form
lesion
accompani
necrosi
pyogen
granulomat
inflamm
sever
studi
investig
potenti
vaccin
prevent
fip
virulenceattenu
live
inactiv
fipv
vaccin
experiment
use
prevent
fip
howev
none
exhibit
suffici
prevent
effect
actual
enhanc
develop
fip
antifcov
antibodyposit
cat
inocul
fipv
onset
time
fip
earlier
antibodyneg
cat
symptom
sever
phenomenon
known
antibodydepend
enhanc
ade
fipv
infect
memori
tcell
shown
rapidli
produc
respons
stimul
inactivatedsar
coronaviru
sarscov
patient
recov
sar
contrast
product
induc
inactivatedsarscov
patient
condit
progress
seriou
state
death
sarscov
infect
base
find
suggest
memori
cell
ie
cellular
immun
respons
may
particip
viral
clearanc
recov
sar
patient
similarli
show
peripher
blood
mononuclear
cell
pbmc
obtain
fipvinfect
nonfip
cat
specif
significantli
produc
felin
heatinactiv
fipv
stimul
fip
cat
result
support
previou
find
helper
th
activ
play
import
role
defens
fipv
infect
thu
induct
activ
essenti
develop
vaccin
fipv
infect
protein
fcov
exist
radial
protrud
trimer
envelop
membran
structur
function
divid
two
domain
name
domain
previous
synthes
peptid
domain
n
protein
induc
product
pbmc
collect
cat
recov
fipv
infect
fipvinfect
nonfip
cat
import
develop
effect
peptidebas
vaccin
fipv
infect
includ
epitop
ade
epitop
present
studi
identifi
linear
immunodomin
antibodybind
epitop
domain
protein
fipv
also
select
peptid
strongli
induc
activ
deriv
structur
protein
n
protein
fipv
base
studi
previou
studi
set
peptid
synthes
sigmaaldrich
usa
thirti
peptid
deriv
domain
type
fipv
strain
tabl
thirti
peptid
deriv
domain
type
ii
fipv
strain
tabl
respect
twentyf
peptid
deriv
protein
type
fipv
strain
tabl
three
peptid
deriv
ntermin
end
protein
type
ii
fipv
strain
tabl
activityinduc
peptid
deriv
domain
n
protein
fipv
prepar
describ
satoh
et
al
peptid
purifi
puriti
higher
suppli
lyophil
powder
peptid
dissolv
dimethyl
sulfoxid
mgml
aliquot
store
c
type
fipv
strain
isol
laboratori
type
ii
fipv
strain
suppli
dr
mc
horzinek
univers
utrecht
fip
develop
cat
inocul
oronas
fipv
strain
develop
approxim
cat
inocul
intraperiton
cat
passiv
immun
antifcov
antibodi
inocul
intraperiton
fipv
strain
approxim
develop
fip
fipv
strain
inocul
oral
induc
fip
approxim
antifcov
antibodyneg
cat
use
antifcov
antibodyneg
specif
pathogenfre
spf
cat
year
old
present
studi
cat
inocul
oral
type
fipv
type
ii
fipv
strain
develop
fip
use
agematch
spf
cat
use
control
cat
maintain
temperaturecontrol
isol
facil
experi
perform
accord
guidelin
anim
experi
kitasato
univers
pbmc
prepar
describ
satoh
et
al
measur
sandwich
elisa
describ
previous
evalu
immun
activ
pbmc
pbmc
cellsml
cultur
synthes
peptid
gml
heatinactiv
viru
fipv
strain
tcid
ml
fipv
strain
tcid
ml
posit
control
cultur
medium
alon
neg
control
c
day
fipv
cultur
fluid
heat
c
min
use
heatinactiv
fipv
elisa
plate
thermo
fisher
scientif
usa
coat
l
unlabel
mab
gml
carbon
buffer
c
overnight
plate
block
block
buffer
wash
l
cultur
supernat
standard
sampl
recombin
r
system
usa
ad
well
incub
c
h
anoth
wash
l
biotinyl
mab
gml
ad
well
plate
incub
c
h
optim
dilut
horseradish
peroxidas
hrp
conjug
streptavidin
millipor
usa
ad
plate
incub
c
min
substrat
solut
prepar
dissolv
ophenylenediamin
dihydrochlorid
concentr
mgml
citric
acid
na
hpo
buffer
ph
ad
lml
h
reaction
stop
n
h
solut
optic
densiti
od
nm
determin
minimum
detect
concentr
defin
standard
deviat
dose
measur
zero
dose
background
level
supernat
interpol
standard
calibr
curv
elisa
plate
sumitomo
bakelit
japan
coat
overnight
c
peptid
lwell
dilut
carbon
buffer
wash
pb
contain
plate
block
block
buffer
contain
block
ace
ds
pharma
japan
pb
c
min
well
plate
receiv
l
plasma
fipv
cat
fipv
cat
spf
cat
min
incub
c
plate
wash
peroxidas
pod
conjug
goat
anticat
igg
mp
biomed
usa
dilut
optim
concentr
l
dilut
ad
well
plate
incub
c
min
plate
wash
well
receiv
l
substrat
solut
incub
c
min
dark
substrat
solut
prepar
dissolv
ophenylenediamin
dihydrochlorid
concentr
mgml
citric
acid
na
hpo
buffer
ph
ad
lml
h
reaction
stop
n
h
solut
optic
densiti
od
nm
determin
felin
immunityinduc
cpgodn
fcpgodn
no
fcpgodn
identifi
satoh
et
al
use
vaccin
adjuv
three
peptid
mgml
fcpgodn
gml
mix
respect
l
mixtur
ad
vial
contain
freezedri
liposom
coatsom
nof
japan
mix
well
solut
dilut
time
pb
use
peptid
cpg
schedul
experi
shown
cat
separ
two
group
control
group
six
cat
administ
pb
mlhead
post
vaccin
day
peptid
cpg
group
six
cat
vaccin
sc
inject
day
peptid
cpg
mlhead
pbmc
collect
day
product
measur
data
two
group
analyz
student
ttest
multipl
group
analyz
oneway
anova
pbmc
obtain
five
fipv
nonfip
cat
male
femal
five
spf
cat
male
femal
cultur
peptid
deriv
domain
fipv
strain
fig
upper
panel
fipv
nonfip
cat
concentr
supernat
pbmc
cultur
heatinactiv
fipv
significantli
higher
pbmc
cultur
medium
alon
howev
signific
increas
observ
level
cultur
supernat
pbmc
cultur
peptid
spf
cat
concentr
supernat
increas
even
pbmc
cultur
either
peptid
reactiv
plasma
collect
five
fipv
nonfip
cat
five
spf
cat
peptid
examin
indirect
elisa
fig
lower
panel
od
valu
plasma
fipv
cat
three
peptid
heatinactiv
fipv
signific
higher
spf
cat
pbmc
obtain
five
fipv
nonfip
cat
male
femal
five
spf
cat
male
femal
cultur
individu
peptid
deriv
domain
fipv
strain
fig
upper
panel
fipv
nonfip
cat
level
supernat
pbmc
cultur
seven
peptid
heatinactiv
fipv
significantli
higher
pbmc
cultur
medium
alon
spf
cat
concentr
supernat
increas
even
pbmc
cultur
either
peptid
reactiv
plasma
collect
five
fipv
nonfip
cat
five
spf
cat
peptid
examin
fig
lower
panel
od
valu
plasma
fipv
cat
three
peptid
significantli
higher
plasma
spf
cat
pbmc
obtain
five
fipv
nonfip
cat
five
fipv
nonfip
cat
five
spf
cat
cultur
peptid
deriv
protein
fipv
strain
strain
fipv
nonfip
cat
concentr
supernat
pbmc
cultur
sixteen
peptid
heatinactiv
fipv
significantli
higher
pbmc
cultur
cultur
medium
alon
fig
upper
panel
fipv
nonfip
cat
level
supernat
pbmc
cultur
seven
peptid
heatinactiv
fipv
significantli
higher
pbmc
cultur
cultur
medium
alon
fig
upper
panel
spf
cat
concentr
supernat
increas
even
pbmc
cultur
either
peptid
reactiv
plasma
collect
five
fipv
nonfip
cat
five
fipv
nonfip
cat
five
spf
cat
peptid
examin
od
valu
plasma
fipv
fipv
cat
three
four
peptid
heatinactiv
viru
respect
significantli
higher
plasma
spf
cat
fig
lower
rescreen
epitop
domain
n
protein
fipv
sever
peptid
deriv
n
protein
fipv
contain
epitop
linear
immunodomin
antibodybind
epitop
identifi
previou
studi
find
peptid
strongli
induc
product
pbmc
collect
fipv
nonfip
cat
select
similarli
peptid
strongli
induc
product
pbmc
collect
fipv
nonfip
cat
select
peptid
induc
significantli
stronger
activ
fipv
antigen
search
peptid
experi
repeat
time
use
increas
number
cat
improv
experiment
accuraci
fipv
nonfip
cat
n
male
femal
level
pbmc
cultur
significantli
higher
pbmc
cultur
heatinactiv
fipv
fig
fipv
nonfip
cat
n
male
femal
level
pbmc
cultur
significantli
higher
pbmc
cultur
heatinactiv
fipv
fig
spf
cat
n
male
femal
concentr
supernat
increas
even
pbmc
cultur
either
peptid
peptid
contain
epitop
strongli
induc
activ
fipv
nonfip
cat
strongli
induc
activ
fipv
nonfip
cat
strongli
induc
activ
fipv
fipv
nonfip
cat
investig
applic
vaccin
induc
fipv
antigenspecif
cell
peptid
mix
activityinduc
fcpgodn
subcutan
administ
twice
spf
cat
pbmc
collect
cat
cultur
peptid
induct
product
investig
fig
vaccin
cat
peptid
cpg
group
n
male
femal
level
pbmc
cultur
significantli
higher
pbmc
obtain
nonvaccin
cat
control
group
n
male
femal
develop
fipprevent
vaccin
requir
antigen
induc
ade
select
ie
region
contain
epitop
antibodybind
epitop
need
identifi
achiev
condit
search
region
contain
epitop
linear
immunodomin
antibodybind
epitop
fipv
structur
protein
use
synthes
peptid
amino
acid
sequenc
domain
protein
differ
markedli
type
fipv
ii
fipv
fig
immun
respons
peptid
pbmc
isol
cat
vaccin
peptid
fcpgodn
liposom
activityinduc
mix
fcpgodn
subcutan
administ
twice
spf
cat
black
bar
n
control
pb
administ
twice
spf
cat
white
bar
n
pbmc
subsequ
collect
cat
cell
cultur
individu
synthes
peptid
heatinactiv
fipv
posit
control
concentr
measur
use
sandwich
elisa
bar
repres
mean
sem
thu
peptid
serotyp
synthes
experi
epitopecontain
peptid
identifi
peptid
deriv
domain
type
fipv
contrast
epitopecontain
peptid
identifi
domain
type
ii
fipv
linear
immunodomin
antibodybind
epitop
contain
peptid
twentytwo
peptid
cover
consensu
amino
acid
sequenc
serotyp
synthes
protein
base
sequenc
type
fipv
three
peptid
synthes
ntermin
region
protein
serotyp
seven
epitopecontain
peptid
common
serotyp
identifi
proteinderiv
peptid
peptid
contain
linear
immunodomin
antibodybind
epitop
base
studi
previou
studi
sever
peptid
contain
epitop
linear
immunodomin
antibodybind
epitop
identifi
peptid
deriv
n
protein
fipv
peptid
applic
vaccineinduc
fipv
antigenspecif
cell
select
peptid
induc
significantli
stronger
activ
fipv
antigen
search
peptid
subsequ
identifi
induc
activ
level
similar
initi
screen
wherea
weakli
induc
activ
type
fipvinfect
nonfip
cat
differ
initi
screen
activ
might
unstabl
thu
exclud
experi
report
cellular
immun
induc
peptid
administ
anim
cellular
immun
inhibit
indic
vaccin
adjuv
necessari
peptidebas
vaccin
induc
cellular
immun
use
fcpgodn
vaccin
adjuv
administr
peptidebas
vaccin
cpgodn
previous
shown
effici
induc
cellular
immun
human
mice
combin
fcpgodn
encapsul
liposom
subcutan
administ
twice
spf
cat
respons
peptid
measur
activ
significantli
induc
respons
suggest
may
applic
vaccin
induc
fipv
antigenspecif
cell
hand
activ
induc
respons
reason
peptid
induc
activ
unclear
necessari
investig
induct
activ
cat
inocul
alon
use
method
moreov
unlik
respons
fipvinfect
nonfip
cat
product
respons
heat
inactivatedfipv
antigen
note
cat
administ
peptid
fcpgodn
recent
report
similar
find
obtain
spf
cat
immun
peptid
deriv
n
protein
fipv
fcpgodn
unclear
heatinactiv
fipv
antigen
induc
product
cat
immun
peptid
fcpgodn
investig
necessari
identifi
reason
identifi
synthet
peptid
includ
linear
immunodomin
antibodybind
epitop
domain
protein
fipv
also
select
peptid
strongli
induc
activ
synthet
peptid
deriv
fipv
structur
protein
futur
necessari
investig
reproduc
experiment
result
analyz
cell
popul
cat
treat
peptid
fcpgodn
use
flow
cytometri
ultim
desir
inocul
cat
type
ii
fipv
immun
fcpgodncombin
peptid
confirm
whether
fip
develop
actual
inhibit
